4.7 Review

Novel Biomarkers, Diagnostic and Therapeutic Approach in Rheumatoid Arthritis Interstitial Lung Disease-A Narrative Review

Related references

Note: Only part of the references are listed.
Article Respiratory System

Connective tissue disease-associated interstitial lung disease

R. P. Oliveira et al.

Summary: Connective tissue diseases (CTD) are frequently associated with interstitial lung disease (ILD), significantly impacting morbidity and mortality. This study analyzed the experience of an autoimmune specialized unit in treating CTD-ILD and characterized the patient population based on common diseases, imaging patterns, lung function tests results, serology, and treatment. It also assessed mortality and mortality predictors, with pulmonary hypertension identified as the most important predictor. The study highlights the importance of chest physicians in these specialized units.

PULMONOLOGY (2022)

Article Medicine, General & Internal

Efficacy and Safety of Rituximab in Autoimmune Disease-Associated Interstitial Lung Disease: A Prospective Cohort Study

Natalia Mena-Vazquez et al.

Summary: The study showed that in patients with connective tissue disease associated interstitial lung disease treated with rituximab, over half of the patients showed improvement or stabilization of the disease at the end of follow-up. Early treatment and combination with mycophenolate could reduce the risk of ILD progression.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Rheumatology

Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from northern Sweden

Elias Jonsson et al.

Summary: This study assessed the association between pulmonary fibrosis (PF) and genetic variants and disease-related factors in rheumatoid arthritis (RA) patients. The results showed that PF in RA patients is associated with four genetic variants. Older age and RF positivity are associated with increased risk, while MTX treatment is associated with a lower risk of PF development.

RHEUMATOLOGY (2022)

Review Respiratory System

Drug-induced interstitial lung disease

Paolo Spagnolo et al.

Summary: Drug-induced interstitial lung disease (ILD) is increasingly common and can have various clinical manifestations. Early identification and discontinuation of the culprit drug are crucial for treatment. Mitigation strategies may be needed for certain drugs to prevent complications.

EUROPEAN RESPIRATORY JOURNAL (2022)

Review Rheumatology

Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management

Yujie Dai et al.

Summary: Rheumatoid arthritis-associated interstitial lung disease is a major factor in increasing morbidity and mortality. Research has shown that antibodies, genetic mutations, and smoking may be associated with the disease's onset. High-resolution computed tomography imaging is more suitable for assessing the condition, while disease-modifying anti-rheumatic drugs like methotrexate, leflunomide, abatacept, and rituximab have shown benefits in prevention and treatment.

CLINICAL RHEUMATOLOGY (2021)

Article Respiratory System

Methotrexate and rheumatoid arthritis associated interstitial, Lung disease

Pierre-Antoine Juge et al.

Summary: The study found that there is no increased risk of RA-ILD associated with MTX use in patients with RA, and that ILD was detected later in MTX-treated patients.

EUROPEAN RESPIRATORY JOURNAL (2021)

Review Rheumatology

Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib

Shigeki Makino

Summary: This paper presents the role of nintedanib in fibrotic lung diseases, discusses the concept and definition of progressive fibrosing ILD, and evaluates its therapeutic effects on specific types of ILD.

MODERN RHEUMATOLOGY (2021)

Review Respiratory System

Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease

Scott Matson et al.

Summary: Although RA-ILD and IPF are distinct diseases, they share several clinical, radiographic, and genetic features, sparking interest in their relationship. Understanding the links between these diseases could fundamentally change strategies for the diagnosis, screening, and treatment of ILD.

EUROPEAN RESPIRATORY JOURNAL (2021)

Review Biochemistry & Molecular Biology

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis

Chao-Yi Wu et al.

Summary: RA is a chronic inflammatory disease involving synovial inflammation and articular destruction. RFs, ACPAs, and anti-CarP Abs have been identified as important autoantibodies in predicting and diagnosing RA, with potential implications for treatment response.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Virology

Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysis

Kai Deng et al.

Summary: KL-6 can serve as a biomarker for assessing COVID-19 severity and predicting lung injury prognosis, with its serum concentration correlated to disease severity and lung lesion areas, maintaining predictive value even after discharge.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Rheumatology

Interstitial lung disease throughout the rheumatoid arthritis disease course

Gregory C. McDermott et al.

Summary: RA-ILD is a serious extra-articular manifestation of RA, with high prevalence throughout the disease course. Autoantibodies like ACPA may play a central role in the development of ILD in RA patients. Further studies are needed to better understand the risk factors, prognosis, and potential therapies for RA-ILD.

CURRENT OPINION IN RHEUMATOLOGY (2021)

Review Rheumatology

Diagnostic value of anti-citrullinated α-enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta-analysis

Haolong Li et al.

Summary: The study evaluated the diagnostic value of anti-CEP 1 antibody in patients with rheumatoid arthritis (RA) and found that it has moderate diagnostic value with relatively low sensitivity and high specificity. The use of ELISA may increase the diagnostic sensitivity of RA.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)

Review Immunology

The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis

Nora Petrovska et al.

Summary: Rheumatoid arthritis (RA) is a chronic autoimmune disease involving a multistep process, with the combination of ACPA and RF increasing the risk of RA development. Early detection of ACPA can predict the onset of RA, and intervention targeting at-risk populations in different stages of RA may be crucial in preventing the disease.

AUTOIMMUNITY REVIEWS (2021)

Review Immunology

Rheumatoid arthritis related interstitial lung disease

Andreina Manfredi et al.

Summary: Rheumatoid arthritis-related interstitial lung disease is a common extra-articular manifestation that significantly impacts patients' quality of life and overall prognosis, necessitating early diagnosis and treatment. High-resolution computed tomography is the gold standard for ILD diagnosis, but determining the correct therapeutic strategy remains challenging due to the high variability of clinical presentation and disease progression. A multidisciplinary approach involving rheumatologists, pulmonologists, and radiologists is currently recommended to define optimal therapy and follow-up strategies.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

Article Critical Care Medicine

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Juergen Behr et al.

Summary: This multicentre, double-blind, randomised, placebo-controlled trial aimed to evaluate the efficacy and safety of pirfenidone in patients with progressive fibrotic interstitial lung diseases. Results after 48 weeks showed a significantly lower decline in FVC % predicted in the pirfenidone group compared to placebo, suggesting that adding pirfenidone to existing treatment might attenuate disease progression in these patients.

LANCET RESPIRATORY MEDICINE (2021)

Article Chemistry, Medicinal

Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice

Satoshi Mizutani et al.

Summary: Anti-CX3CL1 monoclonal antibody treatment showed stronger inhibitory effects against the alveolar infiltration of M1 macrophages compared to M2 macrophages in ILD in SKG mice, suggesting the involvement of the CX3CL1-CX3CR1 axis in inflammatory M1 macrophage infiltration in RA-ILD.

PHARMACEUTICALS (2021)

Article Biochemistry & Molecular Biology

Molecular Signatures of Idiopathic Pulmonary Fibrosis

Iain R. Konigsberg et al.

Summary: This study integrated coding and noncoding transcriptomes, DNA methylomes, and proteomes to identify molecules and pathways associated with idiopathic pulmonary fibrosis (IPF). Analysis of data from 24 IPF subjects and 14 control subjects identified differentially expressed transcripts, abundant proteins, methylated regions, and long noncoding RNAs. The results demonstrated novel molecular relationships in IPF using a system biology approach.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases

Julie Tanguy et al.

Summary: Interstitial lung diseases (ILDs) encompass a wide range of diseases, each with unique clinical patterns and features, making predicting disease progression challenging for individual patients. Heat shock proteins (HSPs) are implicated in fibrogenesis and may hold promise as therapeutic targets and biomarkers in ILDs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Respiratory System

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management

Suha Kadura et al.

Summary: Rheumatoid arthritis (RA) is a systemic inflammatory disorder, with lung involvement being the most common extra-articular manifestation. RA-ILD is a leading cause of death in RA patients with significant morbidity and mortality. Rational clinical approaches for the diagnosis and management of RA-ILD are discussed, along with future directions for research in RA-associated lung disease.

EUROPEAN RESPIRATORY REVIEW (2021)

Article Respiratory System

Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model

Yoko Miura et al.

Summary: RA-ILD is associated with poor prognosis in RA patients. Nintedanib, an antifibrotic drug, showed inhibitory effects on M2 macrophage polarization and hyperplasia of Type 2 alveolar epithelial cells in a novel induced RA-ILD mouse model. The broad inhibitory effects of nintedanib on tyrosine kinases might contribute to the overall improvement in RA-ILD, including epithelial abnormalities associated with progressive lung fibrosis.

ERJ OPEN RESEARCH (2021)

Review Rheumatology

Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders

Masataka Kuwana et al.

Summary: Serum autoantibodies are considered good biomarkers for identifying subsets or specific phenotypes of ILD involvement in patients with autoimmune rheumatic disorders. Different autoantibodies are specifically linked to certain types of ILD, providing important diagnostic and prognostic information for the management of ILD in these patients.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)

Review Rheumatology

Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis

Hiroshi Furukawa et al.

Summary: Interstitial lung disease (ILD) is a common complication of rheumatoid arthritis (RA), with acute-onset diffuse ILD (AoDILD) also occurring in RA patients. While some biomarkers for ILD have been established, more research is needed for biomarkers specific to RA-ILD and AoDILD.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)

Review Rheumatology

The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases

Yukai Wang et al.

Summary: Screening and follow-up of interstitial lung disease associated with rheumatoid arthritis (RA-ILD) is challenging in clinical practice due to majority of patients being asymptomatic and lack of optimal tools for early screening. Usual interstitial pneumonia (UIP) is the most frequent radiological and pathological pattern in RA-ILD, indicating poor prognosis and high risk of acute exacerbations and infections. Lung ultrasound (LUS) and serum Krebs von den Lungen-6 antigen (KL-6) have been recognized as sensitive biomarkers for early detection of ILD, showing significant correlation with high-resolution computed tomography (HRCT) and pulmonary function tests (PFTs) in systemic sclerosis-associated ILD (SSc-ILD).

ARTHRITIS RESEARCH & THERAPY (2021)

Review Pharmacology & Pharmacy

Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis

Sushweta Mahalanobish et al.

PHARMACOLOGICAL RESEARCH (2020)

Letter Critical Care Medicine

Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors

Manuel Silva-Carmona et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Identification of Subclinical Lung Involvement in ACPA-Positive Subjects through Functional Assessment and Serum Biomarkers

Bruno Lucchino et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

A prospective study of lung disease in a cohort of early rheumatoid arthritis patients

A. Robles-Perez et al.

SCIENTIFIC REPORTS (2020)

Article Medicine, General & Internal

Rheumatoid Arthritis Related Interstitial Lung Disease: Patterns of High-resolution Computed Tomography

Mahesh Gautam et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Review Respiratory System

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases

Lutz Wollin et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Letter Medicine, General & Internal

Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease

Zhiwei Chen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Respiratory System

Thoracic Manifestations of Rheumatoid Arthritis

Anthony J. Esposito et al.

CLINICS IN CHEST MEDICINE (2019)

Review Medicine, General & Internal

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians

Elisabeth Bendstrup et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Review Rheumatology

Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis

Zhu Chen et al.

NATURE REVIEWS RHEUMATOLOGY (2019)

Review Rheumatology

Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease

Isabelle Amigues et al.

OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS (2019)

Article Rheumatology

Utility of Anti-Carbamylated Protein Antibodies in the Diagnosis of Early Rheumatoid Arthritis

Ashraf H. Mohamed et al.

INDIAN JOURNAL OF RHEUMATOLOGY (2019)

Review Rheumatology

Rheumatoid arthritis and citrullination

Erika Darrah et al.

CURRENT OPINION IN RHEUMATOLOGY (2018)

Review Biotechnology & Applied Microbiology

Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment

You-Jung Ha et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Review Rheumatology

The Lung in Rheumatoid Arthritis Focus on Interstitial Lung Disease

Paolo Spagnolo et al.

ARTHRITIS & RHEUMATOLOGY (2018)

Review Immunology

Rheumatoid Arthritis and miRNAs: A Critical Review through a Functional View

Maria Cristina Moran-Moguel et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2018)

Review Rheumatology

Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction

V. Michael Holers et al.

NATURE REVIEWS RHEUMATOLOGY (2018)

Review Rheumatology

Extra-articular rheumatoid arthritis

E. Marcucci et al.

REUMATISMO (2018)

Article Rheumatology

Patterns of interstitial lung disease and mortality in rheumatoid arthritis

Jorge A. Zamora-Legoff et al.

RHEUMATOLOGY (2017)

Article Respiratory System

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

Pierre-Antoine Juge et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Article Rheumatology

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts

Yoel Brito et al.

CURRENT RHEUMATOLOGY REPORTS (2017)

Article Rheumatology

Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease

Jorge A. Zamora-Legoff et al.

ARTHRITIS & RHEUMATOLOGY (2017)

Article Respiratory System

Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis

Katerina D. Samara et al.

RESPIRATORY RESEARCH (2017)

Article Orthopedics

Plasma miRNA expression profiles in rheumatoid arthritis associated interstitial lung disease

Shomi Oka et al.

BMC MUSCULOSKELETAL DISORDERS (2017)

Article Rheumatology

Genetic and environmental risk factors for rheumatoid arthritis

Kevin D. Deane et al.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2017)

Article Respiratory System

Characterisation of patients with interstitial pneumonia with autoimmune features

Justin M. Oldham et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Article Biotechnology & Applied Microbiology

Establishment of a Rat Adjuvant Arthritis-Interstitial Lung Disease Model

Liu-nan Song et al.

BIOMED RESEARCH INTERNATIONAL (2016)

Article Critical Care Medicine

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers

Tracy J. Doyle et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Review Medicine, General & Internal

Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Chandra Mohan et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Review Medicine, General & Internal

Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Chandra Mohan et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Article Immunology

Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis

Ger J. M. Pruijn

FRONTIERS IN IMMUNOLOGY (2015)

Review Rheumatology

Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review

Kundan Iqbal et al.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2015)

Article Rheumatology

Biomarkers of Rheumatoid Arthritis-Associated Interstitial Lung Disease

Juan Chen et al.

ARTHRITIS & RHEUMATOLOGY (2015)

Review Rheumatology

The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury?

Elizabeth Perry et al.

RHEUMATOLOGY (2014)

Article Medicine, General & Internal

Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis

Anna L. Peljto et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Review Biotechnology & Applied Microbiology

The Multifaceted Aspects of Interstitial Lung Disease in Rheumatoid Arthritis

Lorenzo Cavagna et al.

BIOMED RESEARCH INTERNATIONAL (2013)

Article Medicine, General & Internal

Interstitial lung disease in connective tissue disorders

Aryeh Fischer et al.

LANCET (2012)

Article Cardiac & Cardiovascular Systems

Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis

Shunsuke Mori et al.

RESPIRATORY MEDICINE (2012)

Letter Rheumatology

HLA-DRB1 Alleles and Rheumatoid Arthritis-related Pulmonary Fibrosis

Kiyoshi Migita et al.

JOURNAL OF RHEUMATOLOGY (2010)

Review Pharmacology & Pharmacy

Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease

Clive Kelly et al.

EXPERT OPINION ON PHARMACOTHERAPY (2008)

Article Rheumatology

Citrullination in extra-articular manifestations of rheumatoid arthritis

T. Bongartz et al.

RHEUMATOLOGY (2007)